PT - JOURNAL ARTICLE AU - Mario Romandini AU - Cristina Lima AU - Ignacio Pedrinaci AU - Ana Araoz AU - Maria Costanza Soldini AU - Mariano Sanz TI - Prevalence and risk/protective indicators of peri-implant diseases: a university-representative cross-sectional study AID - 10.1101/2020.06.04.20121970 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.04.20121970 4099 - http://medrxiv.org/content/early/2020/06/05/2020.06.04.20121970.short 4100 - http://medrxiv.org/content/early/2020/06/05/2020.06.04.20121970.full AB - Aim To evaluate the prevalence of peri-implant diseases and to identify risk/protective indicators of peri-implantitis.Materials and Methods 240 randomly selected patients from a university clinic database were invited to participate. Those who accepted, once data from their medical and dental history was collected, were examined clinically and radiographically to assess the prevalence of peri-implant health and diseases. A multilevel multivariate logistic regression analysis was carried out to identify those factors associated either positively (risk) or negatively (protective) with peri-implantitis defined as BoP/SoP and bone levels ≧2 mm.Results 99 patients with a total of 458 dental implants were analyzed. The prevalence of preperiimplantitis and of peri-implantitis were respectively 56.6% and 31.3% at patient-level, while 27.9% and 31.7% at implant-level. The following factors were identified as risk indicators for periimplantitis: smoking (OR = 3.59; 95%CI:1.52–8.45), moderate/severe periodontitis (OR = 2.77; 95%CI:1.20–6.36), < 16 remaining teeth (OR = 2.23; 95%CI:1.05–4.73), plaque (OR = 3.49; 95%CI:1.13–10.75), implant malposition (too vestibular: OR = 2.85; 95%CI:1.17–6.93), implant brand (Nobel vs. Straumann: OR = 4.41;95% CI:1.76–11.09), restoration type (bridge: OR = 2.47; 95%CI:1.19–5.12), and trauma as reason of tooth loss (OR = 6.51;95% CI:1.45–29.26). Conversely, the following factors were identified as protective indicators: interproximal flossing/brushing (OR = 0.27; 95%CI:0.11–0.68), proton pump inhibitors (OR = 0.08; 95%CI:0.01–0.90) and anticoagulants (OR = 0.08; 95%CI:0.01–0.56).Conclusions Peri-implant diseases are highly prevalent among patients with dental implants in this university-based population. Several factors were identified as risk- and protective-indicators of peri-implantitis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partially funded by the Osteology Foundation through a Young Research Grant to Dr. Mario Romandini (project n. 15-251).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research protocol was ethically approved by the CEIC Hospital Clinico San Carlos, Madrid, Spain (19/182-E).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUpon request to the corresponding author, the data could be shared